1. Home
  2. LIVN vs DKL Comparison

LIVN vs DKL Comparison

Compare LIVN & DKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIVN
  • DKL
  • Stock Information
  • Founded
  • LIVN 1987
  • DKL 2012
  • Country
  • LIVN United Kingdom
  • DKL United States
  • Employees
  • LIVN N/A
  • DKL N/A
  • Industry
  • LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • DKL Natural Gas Distribution
  • Sector
  • LIVN Health Care
  • DKL Energy
  • Exchange
  • LIVN Nasdaq
  • DKL Nasdaq
  • Market Cap
  • LIVN 2.1B
  • DKL 2.1B
  • IPO Year
  • LIVN 1993
  • DKL N/A
  • Fundamental
  • Price
  • LIVN $44.06
  • DKL $37.80
  • Analyst Decision
  • LIVN Buy
  • DKL Buy
  • Analyst Count
  • LIVN 7
  • DKL 4
  • Target Price
  • LIVN $58.57
  • DKL $44.25
  • AVG Volume (30 Days)
  • LIVN 882.2K
  • DKL 201.5K
  • Earning Date
  • LIVN 05-07-2025
  • DKL 05-07-2025
  • Dividend Yield
  • LIVN N/A
  • DKL 11.71%
  • EPS Growth
  • LIVN N/A
  • DKL 7.97
  • EPS
  • LIVN N/A
  • DKL 2.98
  • Revenue
  • LIVN $1,275,380,000.00
  • DKL $938,491,000.00
  • Revenue This Year
  • LIVN $5.79
  • DKL $15.88
  • Revenue Next Year
  • LIVN $5.51
  • DKL $0.37
  • P/E Ratio
  • LIVN N/A
  • DKL $12.61
  • Revenue Growth
  • LIVN 7.62
  • DKL N/A
  • 52 Week Low
  • LIVN $32.48
  • DKL $34.59
  • 52 Week High
  • LIVN $64.48
  • DKL $45.71
  • Technical
  • Relative Strength Index (RSI)
  • LIVN 70.16
  • DKL 42.85
  • Support Level
  • LIVN $35.00
  • DKL $38.25
  • Resistance Level
  • LIVN $37.95
  • DKL $39.65
  • Average True Range (ATR)
  • LIVN 1.30
  • DKL 1.14
  • MACD
  • LIVN 1.06
  • DKL 0.11
  • Stochastic Oscillator
  • LIVN 91.36
  • DKL 39.80

About LIVN LivaNova PLC

UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

About DKL Delek Logistics Partners L.P. Common Units representing Limited Partner Interests

Delek Logistics Partners LP owns and operates logistics and marketing assets for crude oil and intermediate and refined products. The company's segment includes gathering and processing; wholesale marketing and terminalling; storage and transportation and investment in pipeline joint ventures. It generates maximum revenue from the wholesale marketing and terminalling segment, which provides marketing services for the refined products output of the Delek Holdings' refineries, engages in wholesale activity at its terminals and terminals owned by third parties, whereby it purchases light product for sale and exchange to third parties, and provides terminalling services at its refined products terminals to independent third parties and Delek Holdings.

Share on Social Networks: